Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Brain Res

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    July 2017
  1. LI M, Li L, Wang K, Su W, et al
    The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats.
    Brain Res. 2017 Jul 28. pii: S0006-8993(17)30326.
    PubMed     Text format     Abstract available


    May 2017
  2. HOPFNER F, Kunstner A, Muller SH, Kunzel S, et al
    Gut Microbiota in Parkinson Disease in a northern German cohort.
    Brain Res. 2017 May 12. pii: S0006-8993(17)30180.
    PubMed     Text format     Abstract available


    March 2017
  3. CAUQUIL AS, Ory-Magne F, Jardine V, Galitzky M, et al
    Parkinson's patients can rely on perspective cues to perceive 3D space.
    Brain Res. 2017 Mar 18. pii: S0006-8993(17)30125.
    PubMed     Text format     Abstract available


  4. LEE Y, Heo G, Lee KM, Kim AH, et al
    Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Brain Res. 2017 Mar 17. pii: S0006-8993(17)30133.
    PubMed     Text format     Abstract available


    February 2017
  5. BALUCHNEJADMOJARAD T, Rabiee N, Zabihnejad S, Roghani M, et al
    Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERbeta/Nrf2/HO-1 signaling.
    Brain Res. 2017 Feb 23. pii: S0006-8993(17)30092.
    PubMed     Text format     Abstract available


    December 2016
  6. QUINTERO-ESPINOSA D, Jimenez-Del-Rio M, Velez-Pardo C
    Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
    Brain Res. 2016 Dec 29. pii: S0006-8993(16)30844.
    PubMed     Text format     Abstract available


  7. FALQUETTO B, Tuppy M, Potje SR, Moreira TS, et al
    Cardiovascular dysfunction associated with neurodegeneration in an experimental model of parkinson's disease.
    Brain Res. 2016 Dec 9. pii: S0006-8993(16)30819.
    PubMed     Text format     Abstract available


    November 2016
  8. ZHANG ZN, Zhang JS, Xiang J, Yu ZH, et al
    Subcutaneous rotenone rat model of Parkinson's disease: dose exploration study.
    Brain Res. 2016 Nov 19. pii: S0006-8993(16)30776.
    PubMed     Text format     Abstract available


  9. DENG Q, Zhou X, Chen J, Pan M, et al
    Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Brain Res. 2016 Nov 10. pii: S0006-8993(16)30744.
    PubMed     Text format     Abstract available


  10. JANG Y, Koo JH, Kwon I, Kang EB, et al
    Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Brain Res. 2016 Nov 3. pii: S0006-8993(16)30740.
    PubMed     Text format     Abstract available


    September 2016
  11. FARRAND AQ, Gregory RA, Backman CM, Helke KL, et al
    Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
    Brain Res. 2016 Sep 19. pii: S0006-8993(16)30653.
    PubMed     Text format     Abstract available


  12. LIU KC, Li JY, Xie W, Li LB, et al
    Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Brain Res. 2016 Sep 8. pii: S0006-8993(16)30617.
    PubMed     Text format     Abstract available


    August 2016
  13. LEMOS J, Pereira D, Almendra L, Rebelo D, et al
    Distinct functional properties of the vertical and horizontal saccadic network in Health and Parkinson's Disease: an eye-tracking and fMRI study.
    Brain Res. 2016 Aug 18. pii: S0006-8993(16)30520.
    PubMed     Text format     Abstract available


  14. TAMAS G, Kelemen A, Radics P, Valalik I, et al
    Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease.
    Brain Res. 2016 Aug 16. pii: S0006-8993(16)30556.
    PubMed     Text format     Abstract available


    July 2016
  15. MORO C, Massri NE, Darlot F, Torres N, et al
    Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease.
    Brain Res. 2016 Jul 7. pii: S0006-8993(16)30478.
    PubMed     Text format     Abstract available


    June 2016
  16. JIAO J, Guo H, He Y, Wang J, et al
    Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications.
    Brain Res. 2016 Jun 29. pii: S0006-8993(16)30467.
    PubMed     Text format     Abstract available


  17. MOLLAEI F, Shiller DM, Baum SR, Gracco VL, et al
    Sensorimotor control of vocal pitch and formant frequencies in Parkinson's disease.
    Brain Res. 2016 Jun 8. pii: S0006-8993(16)30437.
    PubMed     Text format     Abstract available


    May 2016
  18. HANSEN HH, Fabricius K, Barkholt P, Mikkelsen JD, et al
    Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Brain Res. 2016 May 24. pii: S0006-8993(16)30400.
    PubMed     Text format     Abstract available


  19. SU C, Yang X, Lou J
    Geniposide reduces alpha-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
    Brain Res. 2016 May 9. pii: S0006-8993(16)30366.
    PubMed     Text format     Abstract available


    April 2016
  20. MERCADO G, Castillo V, Soto P, Sidhu A, et al
    ER stress and Parkinson disease: Pathological inputs that converge into the secretory pathway.
    Brain Res. 2016 Apr 18. pii: S0006-8993(16)30260.
    PubMed     Text format     Abstract available


    December 2015
  21. CARRIERE CH, Kang NH, Niles LP
    CHRONIC LOW-DOSE MELATONIN TREATMENT MAINTAINS NIGROSTRIATAL INTEGRITY IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON'S DISEASE.
    Brain Res. 2015 Dec 28. pii: S0006-8993(15)00975.
    PubMed     Text format     Abstract available


  22. ZHANG Z, Hou L, Li X, Ju C, et al
    Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and alpha-synuclein aggregation in 6-OHDA induced parkinson's disease cell model.
    Brain Res. 2015 Dec 28. pii: S0006-8993(15)00974.
    PubMed     Text format     Abstract available


    November 2015
  23. LEDREUX A, Boger HA, Hinson VK, Cantwell K, et al
    BDNF LEVELS ARE INCREASED BY AMINOINDAN AND RASAGILINE IN A DOUBLE LESION MODEL OF PARKINSON'S DISEASE.
    Brain Res. 2015 Nov 19. pii: S0006-8993(15)00872.
    PubMed     Text format     Abstract available


  24. MAHONEY JR, Holtzer R, Izzetoglu M, Zemon V, et al
    The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study.
    Brain Res. 2015 Nov 6. pii: S0006-8993(15)00840.
    PubMed     Text format     Abstract available


    October 2015
  25. JI C, Xue GF, Lijun C, Feng P, et al
    A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Brain Res. 2015 Oct 9. pii: S0006-8993(15)00733.
    PubMed     Text format     Abstract available


  26. LEE Y, Jeong Chun H, Moon Lee K, Jung YS, et al
    Silibinin Suppresses Astroglial Activation in a Mouse Model of Acute Parkinson's Disease by Modulating the ERK and JNK Signaling Pathways.
    Brain Res. 2015 Oct 1. pii: S0006-8993(15)00727.
    PubMed     Text format     Abstract available


    September 2015
  27. SHETTY AK, Bates A
    Potential of GABA-ergic Cell Therapy for Schizophrenia, Neuropathic Pain, and Alzheimer's and Parkinson's Diseases.
    Brain Res. 2015 Sep 27. pii: S0006-8993(15)00717.
    PubMed     Text format     Abstract available


  28. LIU B, Sun J, Zhang J, Mao W, et al
    Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease.
    Brain Res. 2015 Sep 2. pii: S0006-8993(15)00676.
    PubMed     Text format     Abstract available


  29. YAO N, Wu Y, Zhou Y, Ju L, et al
    Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease.
    Brain Res. 2015 Sep 2. pii: S0006-8993(15)00675.
    PubMed     Text format     Abstract available


    August 2015
  30. DOTY KR, Guillot-Sestier MV, Town T
    The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Brain Res. 2015;1617:155-73.
    PubMed     Text format     Abstract available


  31. TOLLESON CM, Dobolyi D, Roman OC, Kanoff K, et al
    Dysrhythmia of timed Movements in Parkinson's disease and freezing of gait.
    Brain Res. 2015 Aug 1. pii: S0006-8993(15)00585.
    PubMed     Text format     Abstract available


    July 2015
  32. WENKER SD, Celeste Leal M, Isabel Farias M, Zeng X, et al
    Cell therapy for Parkinson s disease: Functional role of the Host immune response on survival and differentiation of dopaminergic neuroblasts.
    Brain Res. 2015 Jul 31. pii: S0006-8993(15)00589.
    PubMed     Text format     Abstract available


  33. ZHOU JJ, Zhai SY, Zhang HN, Wang YH, et al
    Neuroprotective effects of 3-O-demethylswertipunicoside against MPTP-induced Parkinsons disease in vivo and its antioxidant properties in vitro.
    Brain Res. 2015 Jul 23. pii: S0006-8993(15)00548.
    PubMed     Text format     Abstract available


    June 2015
  34. LAZZARA CA, Riley RR, Rane A, Andersen JK, et al
    The combination of lithium and L-dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson's disease therapy.
    Brain Res. 2015 Jun 25. pii: S0006-8993(15)00489.
    PubMed     Text format     Abstract available


  35. SHAN L, Diaz O, Zhang Y, Ladenheim B, et al
    L-Dopa induced dyskinesias in Parkinsonian mice: disease severity or L-Dopa history.
    Brain Res. 2015 Jun 15. pii: S0006-8993(15)00475.
    PubMed     Text format     Abstract available


  36. BARRETT PJ, Timothy Greenamyre J
    Post-translational modification of alpha-synuclein in Parkinson's disease.
    Brain Res. 2015 Jun 12. pii: S0006-8993(15)00471.
    PubMed     Text format     Abstract available


  37. BRIGGS CE, Wang Y, Kong B, Woo TU, et al
    Midbrain dopamine neurons in Parkinsons disease exhibit a dysregulated miRNA and target-gene network.
    Brain Res. 2015 Jun 3. pii: S0006-8993(15)00423.
    PubMed     Text format     Abstract available


    April 2015
  38. LIU FT, Chen Y, Yang YJ, Yang L, et al
    Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant alpha-synuclein.
    Brain Res. 2015;1604:52-61.
    PubMed     Text format     Abstract available


    January 2015
  39. SONG L, Cortopassi G
    Mitochondrial complex I defects increase ubiquitin in substantia nigra.
    Brain Res. 2015;1594:82-91.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: